119 related articles for article (PubMed ID: 31693770)
21. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
Chen W; Liu Y; Chen H; Ning H; Ding K
Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
[TBL] [Abstract][Full Text] [Related]
23. MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2.
Huang WT; Zhang H; Jin Z; Li K; Hu C; Li ML; Situ J
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4710-4718. PubMed ID: 32432734
[TBL] [Abstract][Full Text] [Related]
24. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.
Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ
J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862
[TBL] [Abstract][Full Text] [Related]
25. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
Fan H; Zhang YS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.
He JH; Zhang JZ; Han ZP; Wang L; Lv YB; Li YG
J Exp Clin Cancer Res; 2014 Sep; 33(1):72. PubMed ID: 25200485
[TBL] [Abstract][Full Text] [Related]
27. CircPDHX promotes prostate cancer cell progression in vitro and tumor growth in vivo via miR-497-5p/ACSL1 axis.
Chen J; Xie Q; Miao W; Fan J; Zhou X; Li M
Biochem Biophys Res Commun; 2022 Sep; 620():35-41. PubMed ID: 35777132
[TBL] [Abstract][Full Text] [Related]
28. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
29. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
Meng FJ; Meng FM; Wu HX; Cao XF
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
[TBL] [Abstract][Full Text] [Related]
30. LINC01002 Targets miR-650/FLNA Pathway to Suppress Prostate Cancer Progression.
Qian L; Wang Y; Xiong Y; Ren H; Liu S; Chen D; Liu Y
Urol Int; 2023; 107(5):526-538. PubMed ID: 37040719
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
32. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
33. MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1.
Huang H; Xiong Y; Wu Z; He Y; Gao X; Zhou Z; Wang T
Mol Genet Genomic Med; 2020 Apr; 8(4):e1193. PubMed ID: 32107877
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells.
Barlak N; Capik O; Kilic A; Sanli F; Aytatli A; Yazici A; Karatas EA; Ortucu S; Karatas OF
Cell Biol Int; 2021 May; 45(5):1082-1090. PubMed ID: 33501702
[TBL] [Abstract][Full Text] [Related]
37. LncRNA PART1 inhibits glioma proliferation and migration via miR-374b/SALL1 axis.
Deng YW; Shu YG; Sun SL
Neurochem Int; 2022 Jul; 157():105347. PubMed ID: 35490895
[TBL] [Abstract][Full Text] [Related]
38. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
[TBL] [Abstract][Full Text] [Related]
39. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
40. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM
BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
